Literature DB >> 12917482

Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease.

Alan R Brown1, Jeanette Webb1, Selma Rebus2, Robert Walker1, Alun Williams2, John K Fazakerley1.   

Abstract

The temporal course of cerebral cytokine gene expression was investigated in the ME7/CV murine scrapie model to determine any association with neuropathological events. Analysis by RNase protection assay (RPA) demonstrated no transcripts for ILs 2, 3, 4, 5, 6, 7, 10, 12p40 and 13, granulocyte macrophage colony-stimulating factor, IFN-gamma or lymphotoxin-alpha at any time during the course of this disease. Transcripts for transforming growth factor-beta 1 were constitutively expressed in both control and scrapie-infected brain and were elevated at terminal disease. RPA and quantitative real-time RT-PCR detected low levels of transcripts for IL-1 alpha, IL-1 beta and TNF alpha in scrapie-infected brain but only IL-1 beta was elevated consistently in all mice studied. Although glial cell activation within the hippocampus was evident from 100 days post-infection (p.i.), elevated IL-1 beta transcripts (and immunoreactivity) were evident from 180 days p.i., around the time of hippocampal pyramidal neuron loss, and increased steadily thereafter to reach a 3.5-fold increase at terminal disease. Even at their maximum, levels of these transcripts were disproportionately low relative to the degree of glial cell activation. It is concluded that cytokine gene expression in the ME7 scrapie-infected mouse brain, relative to the degree of reactive gliosis, is highly restricted, temporally late and disproportionately low.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917482     DOI: 10.1099/vir.0.19137-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  22 in total

1.  IL-1 family members as candidate genes modulating scrapie susceptibility in sheep: localization, partial characterization, and expression.

Authors:  Ane Marcos-Carcavilla; Jorge H Calvo; Carmen González; Katayoun Moazami-Goudarzi; Pascal Laurent; Maud Bertaud; Hélène Hayes; Anne E Beattie; Carmen Serrano; Jaber Lyahyai; Inmaculada Martín-Burriel; Estefânia Alves; Pilar Zaragoza; Juan J Badiola; Magdalena Serrano
Journal:  Mamm Genome       Date:  2007-01-22       Impact factor: 2.957

2.  Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease.

Authors:  Colm Cunningham; David C Wilcockson; Delphine Boche; V Hugh Perry
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  IP10, KC and M-CSF Are Remarkably Increased in the Brains from the Various Strains of Experimental Mice Infected with Different Scrapie Agents.

Authors:  Jia Chen; Cao Chen; Chao Hu; Lian Liu; Ying Xia; Lin Wang; Wei Yang; Hai-Yan Wu; Wei Zhou; Kang Xiao; Qi Shi; Yuezhang Wu; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Virol Sin       Date:  2020-04-20       Impact factor: 4.327

4.  Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35.

Authors:  Déborah Tribouillard-Tanvier; Brent Race; James F Striebel; James A Carroll; Katie Phillips; Bruce Chesebro
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  Prion infection of mouse brain reveals multiple new upregulated genes involved in neuroinflammation or signal transduction.

Authors:  James A Carroll; James F Striebel; Brent Race; Katie Phillips; Bruce Chesebro
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

6.  Microglial cell line established from prion protein-overexpressing mice is susceptible to various murine prion strains.

Authors:  Yoshifumi Iwamaru; Takato Takenouchi; Kazumasa Ogihara; Megumi Hoshino; Masuhiro Takata; Morikazu Imamura; Yuichi Tagawa; Hiroko Hayashi-Kato; Yuko Ushiki-Kaku; Yoshihisa Shimizu; Hiroyuki Okada; Morikazu Shinagawa; Hiroshi Kitani; Takashi Yokoyama
Journal:  J Virol       Date:  2006-11-22       Impact factor: 5.103

7.  Role of cyclophilin A from brains of prion-infected mice in stimulation of cytokine release by microglia and astroglia in vitro.

Authors:  Déborah Tribouillard-Tanvier; James A Carroll; Roger A Moore; James F Striebel; Bruce Chesebro
Journal:  J Biol Chem       Date:  2011-12-16       Impact factor: 5.157

8.  PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response.

Authors:  Gerald Barry; Lucy Breakwell; Rennos Fragkoudis; Ghassem Attarzadeh-Yazdi; Julio Rodriguez-Andres; Alain Kohl; John K Fazakerley
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

9.  Role of interleukin-1 in prion disease-associated astrocyte activation.

Authors:  Julia Schultz; Anja Schwarz; Sabine Neidhold; Michael Burwinkel; Constanze Riemer; Dietrich Simon; Manfred Kopf; Markus Otto; Michael Baier
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

10.  Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.

Authors:  Déborah Tribouillard-Tanvier; James F Striebel; Karin E Peterson; Bruce Chesebro
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.